These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34372514)

  • 1. HCV Spread Kinetics Reveal Varying Contributions of Transmission Modes to Infection Dynamics.
    Durso-Cain K; Kumberger P; Schälte Y; Fink T; Dahari H; Hasenauer J; Uprichard SL; Graw F
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.
    Graw F; Martin DN; Perelson AS; Uprichard SL; Dahari H
    J Virol; 2015 Jul; 89(13):6551-61. PubMed ID: 25833046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Viral Spread.
    Graw F; Perelson AS
    Annu Rev Virol; 2016 Sep; 3(1):555-572. PubMed ID: 27618637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Hepatitis C Virus Modeling Predicts Infection Dynamics and Viral Protein Mechanisms.
    Aunins TR; Marsh KA; Subramanya G; Uprichard SL; Perelson AS; Chatterjee A
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission.
    Fofana I; Xiao F; Thumann C; Turek M; Zona L; Tawar RG; Grunert F; Thompson J; Zeisel MB; Baumert TF
    PLoS One; 2013; 8(5):e64221. PubMed ID: 23704981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
    Xiao F; Fofana I; Heydmann L; Barth H; Soulier E; Habersetzer F; Doffoël M; Bukh J; Patel AH; Zeisel MB; Baumert TF
    PLoS Pathog; 2014 May; 10(5):e1004128. PubMed ID: 24830295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.
    Xiao F; Wang S; Barouch-Bentov R; Neveu G; Pu S; Beer M; Schor S; Kumar S; Nicolaescu V; Lindenbach BD; Randall G; Einav S
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
    Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    Fan H; Qiao L; Kang KD; Fan J; Wei W; Luo G
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28404852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
    Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
    J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building a mechanistic mathematical model of hepatitis C virus entry.
    Kalemera M; Mincheva D; Grove J; Illingworth CJR
    PLoS Comput Biol; 2019 Mar; 15(3):e1006905. PubMed ID: 30883541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
    von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral dynamics in hepatitis C.
    Kershenobich D; Henonin CH
    Isr Med Assoc J; 2001 May; 3(5):360-3. PubMed ID: 11411202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.
    Padmanabhan P; Dixit NM
    PLoS One; 2012; 7(4):e36107. PubMed ID: 22545157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance.
    Shekhtman L; Navasa M; Sansone N; Crespo G; Subramanya G; Chung TL; Cardozo-Ojeda EF; Pérez-Del-Pulgar S; Perelson AS; Cotler SJ; Forns X; Uprichard SL; Dahari H
    Elife; 2021 Nov; 10():. PubMed ID: 34730511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells.
    Ramakrishnaiah V; Thumann C; Fofana I; Habersetzer F; Pan Q; de Ruiter PE; Willemsen R; Demmers JA; Stalin Raj V; Jenster G; Kwekkeboom J; Tilanus HW; Haagmans BL; Baumert TF; van der Laan LJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13109-13. PubMed ID: 23878230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.
    Gondar V; Molina-Jiménez F; Hishiki T; García-Buey L; Koutsoudakis G; Shimotohno K; Benedicto I; Majano PL
    J Virol; 2015 Oct; 89(19):9962-73. PubMed ID: 26202245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
    Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
    J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.
    Major M; Gutfraind A; Shekhtman L; Cui Q; Kachko A; Cotler SJ; Hajarizadeh B; Sacks-Davis R; Page K; Boodram B; Dahari H
    Sci Transl Med; 2018 Jul; 10(449):. PubMed ID: 29997251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.